Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

Author： Vinod K Yaragudri Hungund Basalingappa L

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.2, 2006-04, pp. : 203-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders

By Hayashi T. Su T-P.

CNS Drugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 269-284

Adis International

Access to resources Recommend Favorite

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders

By Marenco Stefano Weinberger Daniel R.

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 173-185

Adis International

Access to resources Recommend Favorite